... Clinic, Scottsdale, Arizona, USA. Address for reprint requests: Patrick Liu, MD, Department o... more ... Clinic, Scottsdale, Arizona, USA. Address for reprint requests: Patrick Liu, MD, Department of Radiology, Mayo Clinic, 13400 East Shea Boulevard, Scottsdale, Ari-zona 85259, USA; [email protected]. studies were as follows ...
This article describes the unique practice of nurse-driven titration of continuous insulin infusi... more This article describes the unique practice of nurse-driven titration of continuous insulin infusion in postYcardiac surgery patients in the intensive care unit at a tertiary care teaching hospital. A prospective quality assurance study was conducted to support our innovative practice.
Extracorporeal membrane oxygenation (ECMO) for severe acute respiratory failure was proposed more... more Extracorporeal membrane oxygenation (ECMO) for severe acute respiratory failure was proposed more than 40 years ago. Despite the publication of the ARDSNet study and adoption of lung protective ventilation, the mortality for acute respiratory failure due to acute respiratory distress syndrome has continued to remain high. This technology has evolved over the past couple of decades and has been noted to be safe and successful, especially during the worldwide H1N1 influenza pandemic with good survival rates. The primary indications for ECMO in acute respiratory failure include severe refractory hypoxemic and hypercarbic respiratory failure in spite of maximum lung protective ventilatory support. Various triage criteria have been described and published. Contraindications exist when application of ECMO may be futile or technically impossible. Knowledge and appreciation of the circuit, cannulae, and the physiology of gas exchange with ECMO are necessary to ensure lung rest, efficiency of oxygenation, and ventilation as well as troubleshooting problems. Anticoagulation is a major concern with ECMO, and the evidence is evolving with respect to diagnostic testing and use of anticoagulants. Clinical management of the patient includes comprehensive critical care addressing sedation and neurologic issues, ensuring lung recruitment, diuresis, early enteral nutrition, treatment and surveillance of infections, and multisystem organ support. Newer technology that delinks oxygenation and ventilation by extracorporeal carbon dioxide removal may lead to ultra-lung protective ventilation, avoidance of endotracheal intubation in some situations, and ambulatory therapies as a bridge to lung transplantation. Risks, complications, and long-term outcomes and resources need to be considered and weighed in before widespread application. Ethical challenges are a reality and a multidisciplinary approach that should be adopted for every case in consideration.
The Canadian Journal of Infectious Diseases Journal Canadien Des Maladies Infectieuses, Jun 1, 2003
A rare fatal case of pulmonary coccidioidomycosis complicated by mediastinal and visceral abscess... more A rare fatal case of pulmonary coccidioidomycosis complicated by mediastinal and visceral abscesses treated with antifungal medications is described. The case report discusses the potential need for early surgical intervention to drain mediastinal and visceral abscesses as a primary mode of therapy in disseminated coccidioidomycosis for a successful control of infection and clinical outcome.
Mechanical circulatory assist devices are now commonly used in the treatment of severe heart fail... more Mechanical circulatory assist devices are now commonly used in the treatment of severe heart failure as bridges to cardiac transplant, as destination therapy for patients who are not transplant candidates, and as bridges to recovery and "decision-making". These devices, which can be used to support the left or right ventricles or both, restore circulation to the tissues, thereby improving organ function. Left ventricular assist devices (LVADs) are the most common support devices. To care for patients with these devices, health care providers in emergency departments (EDs) and intensive care units (ICUs) need to understand the physiology of the devices, the vocabulary of mechanical support, the types of complications patients may have, diagnostic techniques, and decision-making regarding treatment. Patients with LVADs who come to the ED or are admitted to the ICU usually have nonspecific clinical symptoms, most commonly shortness of breath, hypotension, anemia, chest pain, syncope, hemoptysis, gastrointestinal bleeding, jaundice, fever, oliguria and hematuria, altered mental status, headache, seizure, and back pain. Other patients are seen for cardiac arrest, psychiatric issues, sequelae of noncardiac surgery, and trauma. Although most patients have LVADs, some may have biventricular support devices or total artificial hearts. Involving a team of cardiac surgeons, perfusion experts, and heart-failure physicians, as well as ED and ICU physicians and nurses, is critical for managing treatment for these patients and for successful outcomes. This review is designed for critical care providers who may be the first to see these patients in the ED or ICU.
The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses, 2003
A rare fatal case of pulmonary coccidioidomycosis complicated by mediastinal and visceral abscess... more A rare fatal case of pulmonary coccidioidomycosis complicated by mediastinal and visceral abscesses treated with antifungal medications is described. The case report discusses the potential need for early surgical intervention to drain mediastinal and visceral abscesses as a primary mode of therapy in disseminated coccidioidomycosis for a successful control of infection and clinical outcome.
To clarify the relationship of patient and critical illness characteristics (including any histor... more To clarify the relationship of patient and critical illness characteristics (including any history of diabetes mellitus) to glycemic control with insulin and hospital mortality. A case-control descriptive study was performed of patients admitted to a tertiary-care center multidisciplinary closed intensive care unit (ICU) at Mayo Clinic Hospital in Phoenix, Ariz, between January 1, 1999, and December 31, 2003, after implementation of a glycemic management protocol. Hospital mortality, the primary outcome, was examined in nondiabetic and diabetic ICU patients receiving insulin and in patients not requiring insulin (control group). Of 7285 patients, 2826 (39%) required insulin, 1083 of whom (15% of total) had a history of diabetes mellitus. The control group had a median (10th-90th percentile) glucose level of 118 mg/dL (range, 97-153 mg/dL) and a 5% mortality rate. The median glucose level was 134 mg/dL (range, 110-181 mg/dL) in nondiabetic patients and 170 mg/dL (121-238 mg/dL) in diabetic patients (P<.001), whereas mortality rates were 10% and 6%, respectively (P<.001). Compared with nondiabetic survivors, nondiabetic nonsurvivors had longer periods with glucose levels greater than 144 mg/dL. Diabetic nonsurvivors vs diabetic survivors had longer periods with glucose levels greater than 200 mg/dL. Poor glycemic control in nondiabetic patients was associated with increased insulin requirement and increased mortality. Critical illness characteristics that predicted poor glycemic control were advanced age, history of diabetes, cardiac surgery, postoperative complications, severity of illness, nosocomial infections, prolonged mechanical ventilation, or concurrent medications. Critical illness characteristics determined glycemic control and clinical outcome in ICU patients. Acute insulin resistance was associated with worse outcomes in nondiabetic patients. Although critical illness characteristics influenced glycemic control, future evaluation of the effect of insulin administration and optimal glycemic control in ICU patients is necessary.
This article describes the unique practice of nurse-driven titration of continuous insulin infusi... more This article describes the unique practice of nurse-driven titration of continuous insulin infusion in post-cardiac surgery patients in the intensive care unit at a tertiary care teaching hospital. A prospective quality assurance study was conducted to support our innovative practice.
... Clinic, Scottsdale, Arizona, USA. Address for reprint requests: Patrick Liu, MD, Department o... more ... Clinic, Scottsdale, Arizona, USA. Address for reprint requests: Patrick Liu, MD, Department of Radiology, Mayo Clinic, 13400 East Shea Boulevard, Scottsdale, Ari-zona 85259, USA; [email protected]. studies were as follows ...
... Clinic, Scottsdale, Arizona, USA. Address for reprint requests: Patrick Liu, MD, Department o... more ... Clinic, Scottsdale, Arizona, USA. Address for reprint requests: Patrick Liu, MD, Department of Radiology, Mayo Clinic, 13400 East Shea Boulevard, Scottsdale, Ari-zona 85259, USA; [email protected]. studies were as follows ...
This article describes the unique practice of nurse-driven titration of continuous insulin infusi... more This article describes the unique practice of nurse-driven titration of continuous insulin infusion in postYcardiac surgery patients in the intensive care unit at a tertiary care teaching hospital. A prospective quality assurance study was conducted to support our innovative practice.
Extracorporeal membrane oxygenation (ECMO) for severe acute respiratory failure was proposed more... more Extracorporeal membrane oxygenation (ECMO) for severe acute respiratory failure was proposed more than 40 years ago. Despite the publication of the ARDSNet study and adoption of lung protective ventilation, the mortality for acute respiratory failure due to acute respiratory distress syndrome has continued to remain high. This technology has evolved over the past couple of decades and has been noted to be safe and successful, especially during the worldwide H1N1 influenza pandemic with good survival rates. The primary indications for ECMO in acute respiratory failure include severe refractory hypoxemic and hypercarbic respiratory failure in spite of maximum lung protective ventilatory support. Various triage criteria have been described and published. Contraindications exist when application of ECMO may be futile or technically impossible. Knowledge and appreciation of the circuit, cannulae, and the physiology of gas exchange with ECMO are necessary to ensure lung rest, efficiency of oxygenation, and ventilation as well as troubleshooting problems. Anticoagulation is a major concern with ECMO, and the evidence is evolving with respect to diagnostic testing and use of anticoagulants. Clinical management of the patient includes comprehensive critical care addressing sedation and neurologic issues, ensuring lung recruitment, diuresis, early enteral nutrition, treatment and surveillance of infections, and multisystem organ support. Newer technology that delinks oxygenation and ventilation by extracorporeal carbon dioxide removal may lead to ultra-lung protective ventilation, avoidance of endotracheal intubation in some situations, and ambulatory therapies as a bridge to lung transplantation. Risks, complications, and long-term outcomes and resources need to be considered and weighed in before widespread application. Ethical challenges are a reality and a multidisciplinary approach that should be adopted for every case in consideration.
The Canadian Journal of Infectious Diseases Journal Canadien Des Maladies Infectieuses, Jun 1, 2003
A rare fatal case of pulmonary coccidioidomycosis complicated by mediastinal and visceral abscess... more A rare fatal case of pulmonary coccidioidomycosis complicated by mediastinal and visceral abscesses treated with antifungal medications is described. The case report discusses the potential need for early surgical intervention to drain mediastinal and visceral abscesses as a primary mode of therapy in disseminated coccidioidomycosis for a successful control of infection and clinical outcome.
Mechanical circulatory assist devices are now commonly used in the treatment of severe heart fail... more Mechanical circulatory assist devices are now commonly used in the treatment of severe heart failure as bridges to cardiac transplant, as destination therapy for patients who are not transplant candidates, and as bridges to recovery and "decision-making". These devices, which can be used to support the left or right ventricles or both, restore circulation to the tissues, thereby improving organ function. Left ventricular assist devices (LVADs) are the most common support devices. To care for patients with these devices, health care providers in emergency departments (EDs) and intensive care units (ICUs) need to understand the physiology of the devices, the vocabulary of mechanical support, the types of complications patients may have, diagnostic techniques, and decision-making regarding treatment. Patients with LVADs who come to the ED or are admitted to the ICU usually have nonspecific clinical symptoms, most commonly shortness of breath, hypotension, anemia, chest pain, syncope, hemoptysis, gastrointestinal bleeding, jaundice, fever, oliguria and hematuria, altered mental status, headache, seizure, and back pain. Other patients are seen for cardiac arrest, psychiatric issues, sequelae of noncardiac surgery, and trauma. Although most patients have LVADs, some may have biventricular support devices or total artificial hearts. Involving a team of cardiac surgeons, perfusion experts, and heart-failure physicians, as well as ED and ICU physicians and nurses, is critical for managing treatment for these patients and for successful outcomes. This review is designed for critical care providers who may be the first to see these patients in the ED or ICU.
The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses, 2003
A rare fatal case of pulmonary coccidioidomycosis complicated by mediastinal and visceral abscess... more A rare fatal case of pulmonary coccidioidomycosis complicated by mediastinal and visceral abscesses treated with antifungal medications is described. The case report discusses the potential need for early surgical intervention to drain mediastinal and visceral abscesses as a primary mode of therapy in disseminated coccidioidomycosis for a successful control of infection and clinical outcome.
To clarify the relationship of patient and critical illness characteristics (including any histor... more To clarify the relationship of patient and critical illness characteristics (including any history of diabetes mellitus) to glycemic control with insulin and hospital mortality. A case-control descriptive study was performed of patients admitted to a tertiary-care center multidisciplinary closed intensive care unit (ICU) at Mayo Clinic Hospital in Phoenix, Ariz, between January 1, 1999, and December 31, 2003, after implementation of a glycemic management protocol. Hospital mortality, the primary outcome, was examined in nondiabetic and diabetic ICU patients receiving insulin and in patients not requiring insulin (control group). Of 7285 patients, 2826 (39%) required insulin, 1083 of whom (15% of total) had a history of diabetes mellitus. The control group had a median (10th-90th percentile) glucose level of 118 mg/dL (range, 97-153 mg/dL) and a 5% mortality rate. The median glucose level was 134 mg/dL (range, 110-181 mg/dL) in nondiabetic patients and 170 mg/dL (121-238 mg/dL) in diabetic patients (P<.001), whereas mortality rates were 10% and 6%, respectively (P<.001). Compared with nondiabetic survivors, nondiabetic nonsurvivors had longer periods with glucose levels greater than 144 mg/dL. Diabetic nonsurvivors vs diabetic survivors had longer periods with glucose levels greater than 200 mg/dL. Poor glycemic control in nondiabetic patients was associated with increased insulin requirement and increased mortality. Critical illness characteristics that predicted poor glycemic control were advanced age, history of diabetes, cardiac surgery, postoperative complications, severity of illness, nosocomial infections, prolonged mechanical ventilation, or concurrent medications. Critical illness characteristics determined glycemic control and clinical outcome in ICU patients. Acute insulin resistance was associated with worse outcomes in nondiabetic patients. Although critical illness characteristics influenced glycemic control, future evaluation of the effect of insulin administration and optimal glycemic control in ICU patients is necessary.
This article describes the unique practice of nurse-driven titration of continuous insulin infusi... more This article describes the unique practice of nurse-driven titration of continuous insulin infusion in post-cardiac surgery patients in the intensive care unit at a tertiary care teaching hospital. A prospective quality assurance study was conducted to support our innovative practice.
... Clinic, Scottsdale, Arizona, USA. Address for reprint requests: Patrick Liu, MD, Department o... more ... Clinic, Scottsdale, Arizona, USA. Address for reprint requests: Patrick Liu, MD, Department of Radiology, Mayo Clinic, 13400 East Shea Boulevard, Scottsdale, Ari-zona 85259, USA; [email protected]. studies were as follows ...
Uploads
Papers by Joel Larson